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The 25-kb linear plasmid lp25 and one of the 28-kb linear plasmids (lp28-1) are required for experimental
infection in Borrelia burgdorferi, the etiologic agent of Lyme disease. The loss of these plasmids either
eliminates infectivity (lp25) or significantly increases the 50% infective dose during a 2-week infection period
(lp28-1). This study assessed the kinetics of bacterial dissemination in C3H/HeN mice infected with B.
burgdorferi lacking either lp25 or lp28-1, as well as their wild-type parent, and tracked the development of
specific borrelial antibodies over a 3-week period. The results indicated that the wild type and the lp28-1
strains were able to disseminate throughout the host, whereas the lp25 strain was cleared within 48 h of
inoculation. While the wild-type B. burgdorferi persisted in tissues for the duration of the study, the lp28-1
mutant began clearing at day 8, with no detectable bacteria present by day 18. As expected, the wild-type strain
persisted in C3H/HeN mice despite a strong humoral response; however, the lp28-1 mutant was cleared
coincidently with the development of a modest immunoglobulin M response. The lp28-1 mutant was able to
disseminate and persist in C3H-scid mice at a level indistinguishable from that of wild-type cells, confirming
that acquired immunity was required for clearance in C3H/HeN mice. Thus, within an immunocompetent host,
lp28-1-encoded proteins are not required for dissemination but are essential for persistence associated with
Lyme borreliosis.
Lyme disease or Lyme borreliosis is a multisystemic disorder
transmitted by ticks of the genus Ixodes infected with the spi-
rochetal bacterium Borrelia burgdorferi sensu lato, composed of
B. burgdorferi sensu stricto, B. garinii, and B. afzelii (1, 8, 16).
Lyme disease is the leading zoonotic infection in the United
States, accounting for 95% of all reported vector-borne illness
(10). The completed B. burgdorferi sensu stricto strain B31
annotated sequence revealed an unusual genome containing a
linear chromosome of 910 kb in size as well as several extra-
chromosomal elements, including 12 linear plasmids of sizes
ranging from 5 to 56 kb and 9 circular plasmids with sizes
between 9 and 32 kb (9, 14).
Early studies had demonstrated a correlation between plas-
mid content and infectivity but were hindered by the plethora
of plasmid species in B. burgdorferi and the inherent difficulty
in resolving the many linear and circular species (24, 29–31).
As such, prior to the information gained from the B. burgdorferi
strain B31 genome sequence, it was difficult to definitively link
a specific plasmid to a defect in infectivity. Exploiting the
completed genome sequence of B. burgdorferi, we designed
oligonucleotide primers that could be used in conjunction with
PCR to specifically catalog the presence of plasmids from
clonal isolates of B. burgdorferi (17). In our quest to link in-
fectivity to any of the plasmids, we determined, along with
others, that two linear plasmids, 25 and 28 kb in size (desig-
nated lp25 and lp28-1, respectively), were required for maxi-
mal infectivity in the mouse model of infection, suggesting that
these plasmids encode proteins important for survival of B.
burgdorferi in the mammalian host (17, 27). In addition, Mc-
Dowell et al. demonstrated that the loss of infectivity of B.
burgdorferi does not always correlate with plasmid content,
indicating that other plasmid-independent mechanisms are in-
volved in pathogenesis (22).
An initial report indicated that cells lacking lp25 were com-
pletely noninfectious, whereas cells missing lp28-1 were still
infectious, as B. burgdorferi could be isolated from joint tissue
14 days following inoculation (17). It was speculated that cells
missing lp28-1 might also prove to be defective in persistence
in this tissue in a prolonged experimental infection (17). Fur-
thermore, it is not known how the absence of lp25 and lp28-1
affects the kinetics of visceral dissemination, and no serological
analysis was evaluated to determine the humoral response to
the mutant strains. As such, the role of host immune mecha-
nisms in the accelerated clearance of the mutants relative to
their wild-type parent has not been characterized.
In this study, we tested the hypothesis that cells lacking
plasmids lp25 and lp28-1 have distinct dissemination kinetics
during the course of infection in the murine animal model of
Lyme disease. Furthermore, we were interested in determining
the role that adaptive immunity played in the clearance of the
mutants, since the parent isolate is not affected by the robust
humoral immune response observed following infection. The
results obtained indicate that cells lacking lp25 do not survive
in the host and are quickly eliminated. Moreover, these data
demonstrate that lp28-1 is not required for disseminated in-
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fection in the mouse animal model of Lyme borreliosis but is
essential for persistent infection by B. burgdorferi.
MATERIALS AND METHODS
Bacterial strains. B. burgdorferi sensu stricto strain B31 was used exclusively in
this study. The clonal derivatives of strain B31 used have been previously de-
scribed: MSK5 contains all the plasmids, MSK10 is missing lp28-1, and ML23
lacks lp25 (17). All B. burgdorferi cultures were grown in 1% CO2 at 32°C in
BSK-II liquid medium lacking gelatin (2) and supplemented with 6% normal
rabbit serum (Pel-Freez Biologicals, Rogers, Ark.).
Infection experiments. All animal procedures were done in accordance with
recommended and approved protocols from the Texas A&M University Labo-
ratory Animal Care Committee. Eight-week-old C3H/HeN (Charles River Lab-
oratories, Wilmington, Mass.) or C3H/Smn.ClcrHsd-scid (C3H-scid) (Harlan
Laboratories, Philadelphia, Pa.) female mice were separately infected by intra-
dermal inoculation with either 103 or 105 bacteria of the three different B.
burgdorferi B31 isolates tested: MSK5 (wild type), MSK10 (lp28-1), and ML23
(lp25). Mice were sacrificed at different time points, depending on the mouse
strain used and the borrelial isolate used for infection. Immune-competent an-
imals were sacrificed at 11 different time points (4 mice per time point): 1, 2, 4,
6, 8, 10, 12, 14, 16, 18, and 21 days following intradermal inoculation with either
MSK5 or MSK10. C3H/HeN mice infected with 105 ML23 organisms were
sacrificed on days 1, 2, 4, 6, 8, 10, 12, and 14; mice infected with 103 ML23
organisms were sacrificed on days 1, 2, and 4 only. The scid mice were sacrificed
as follows. MSK10-infected mice were sacrificed on days 4, 6, 8, 12, and 14
postinfection; MSK5-infected mice were sacrificed on days 7 and 14 postinfec-
tion, and ML23-infected mice were sacrificed at 7 days postinfection. For all
infectivity studies, the spleen, left tibiotarsal joint, left inguinal lymph node,
heart, bladder, and a piece of abdominal skin were removed aseptically, pro-
cessed using sterile pestles, and placed in liquid BSK-II medium. Cultures were
passaged 5 days later into fresh BSK-II medium to minimize toxicity associated
with host tissue. Tubes were examined for borrelial growth every week thereafter
and up to 21 days using dark field microscopy; tissue samples were considered
positive if actively motile spirochetes were observed (after scanning approxi-
mately 100 fields).
Infection-derived sera. Serum from 4 mice per time point was obtained at days
1, 2, 4, 6, 8, 10, 12, 14, 18, and 21 postinfection by retro-orbital bleed prior to
sacrifice and was processed and stored as previously described (15).
ELISA. Ninety-six-well enzyme-linked immunosorbent assay (ELISA) plates
(Dynex Technologies Inc., Chantilly, Va.) were coated with 100 l of in vitro-
grown low-passage wild-type infectious B. burgdorferi total sonicate (25 g/ml)
per well in coating buffer (50 mM sodium carbonate, pH 9.6) and incubated at
4°C overnight. After three 3-min washes with 200 l of phosphate-buffered saline
(PBS)-Tween buffer (0.80 mM Na2HPO4, 137 mM NaCl, 0.27 mM KCl, 0.15 mM
KH2PO4, and 0.5% Tween 20 [pH 7.4]), 200 l of blocking buffer (PBS-Tween
buffer supplemented with 3% bovine serum albumin) was applied to each well
and incubated for 2 h at 37°C. The wells were washed three times with 200 l of
PBS-Tween buffer. Twofold serial dilutions of mouse serum, ranging from 1:200
to 1:25,600 (in 100-l volumes), were placed in blocking buffer (PBS-Tween
buffer supplemented with 1% bovine serum albumin) and added to each well,
and the plates were incubated for 1 h at 37°C. Each serum sample from an
individually infected mouse was assayed in triplicate at the time points indicated
above. Serum samples from a given time point were not pooled. Normal mouse
serum was diluted (starting at 1:200 and twofold serially diluted to 1:25,600) and
assayed in triplicate to establish a baseline. After the primary antibody incuba-
tion, the wells were washed five times with PBS-Tween. Subsequently, 100 l of
goat anti-mouse immunoglobulin G (IgG) or goat anti-mouse IgM (Pierce En-
dogen, Rockford, Ill.), each conjugated to horseradish peroxidase and dissolved
in blocking buffer, was diluted 1:5,000 and added to each well, and the plates
were incubated at 37°C for 1 h. After five washes with PBS-Tween buffer, 100 l
of o-phenylenediamine dihydrochloride (Sigma Chemical, St. Louis, Mo.) was
added. Development of the enzymatic reaction proceeded for 10 min. The plates
were read at 490 nm in an ELISA plate reader (MR5000; Dynatech). The values
for optical density at 490 nm obtained for each mouse at a given time point were
averaged, and their standard deviation was determined. The titer for an individ-
ual mouse serum sample from a given time point was determined to be the
reciprocal of the highest dilution that was greater than twice the average value
obtained for the normal mouse serum sample at the same dilution value.
RESULTS
Kinetics of infection in immunocompetent C3H/HeN mice.
Previous observations indicated that B. burgdorferi lacking lp25
or lp28-1 was significantly attenuated in the mouse model of
infection (17, 27). Specifically, lp25 mutants were never recov-
ered from mouse tissues, whereas lp28-1 mutants were found
only in joint tissue. Based on these observations, we speculated
that lp28-1 mutants had a tropism for joint tissue. However,
since all prior infection studies were limited to a single termi-
nal 2-week sample, we were interested in determining the
kinetics of dissemination to all tissues, including joints, for the
mutants relative to that for their wild-type parent. To address
this, we infected mice with the parent strain, infected the lp25
and lp28-1 mutants at two different inocula, and sacrificed
animals at days 1 and 2 and then every 2 days to day 18. A final
sample was taken also at day 21. Tissue samples were culti-
vated in BSK-II medium and were examined for borrelial
growth by dark-field microscopy, and the cultures were con-
sidered positive if actively motile spirochetes were observed up
to 3 weeks after the mice were sacrificed. The results shown in
Fig. 1 indicate that MSK5, the parent strain, was able to dis-
seminate to all the tissues tested by day 6 at the low inoculum
(103 organisms) (Fig. 1A) and by day 4 at the large inoculum
(105 organisms) (Fig. 1B). All tissues tested remained infected
for the duration of the study for MSK5 samples. MSK10, the
isolate lacking lp28-1, was able to disseminate to all the tissues
by day 6 at the low inoculum (Fig. 1C) and by day 4 at the high
inoculum (Fig. 1D). When the low inoculum was used, the
number of infected tissues started to decline at day 10, and by
day 18, no organisms could be recovered (Fig. 1C). At the high
inoculum, the number of tissues infected with MSK10 started
to decline at day 8 until no organisms could be recovered by
day 18 (Fig. 1D). The ML23 isolate, lacking lp25, was recov-
ered 24 h after infection in the either the skin or, additionally,
the lymph node and spleen at an inoculum of 103 or 105
organisms, respectively (Fig. 1E and F). No samples were cul-
ture positive for ML23 in any tissue at either inoculum follow-
ing 48 h of infection (Fig. 1E and F).
Measurement of immunoglobulin levels. Previous studies
have shown that passive transfer of antisera leads to protection
against B. burgdorferi infection, indicating that humoral mech-
anisms are sufficient for the clearance observed (4, 11, 34). To
determine if the differences in the clearance of the mutants
correlates with the development of the humoral response ob-
served, the levels of both IgM and IgG were measured for four
separate mice at each of the aforementioned time points by
ELISAs (Table 1), and a range of titers was then determined
for each time point. At an inoculum of 103 organisms, IgM
levels could be detected for both MSK5 (wild type) and
MSK10 (lp28-1), with levels that peaked at day 14 for MSK5
(with titers ranging from 1:3,200 to 1:12,800) and at day 10 for
MSK10 (with titers ranging from undetectable levels up to
1:3,200) (Table 1). At the higher inoculum, the IgM levels
peaked at day 12 and day 10 with an endpoint titer varying
from 1:1,600 to 1:3,200 for MSK5 and from 1:1,600 to 1:6,400
for MSK10, respectively (Table 1). When mice were infected
with an inoculum of 103 MSK5 organisms, IgG was detected by
day 12 and rose to endpoint titers ranging from 1:6,400 to
1:12,800 by day 16, whereas only sparse levels of IgG were
VOL. 71, 2003 INFECTION KINETICS OF B. BURGDORFERI MUTANT STRAINS 4609
 o
n
 Septem
ber 19, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
detected in mice infected with 103 MSK10 organisms (Table 1).
With an inoculum dose of 105 MSK5 organisms, IgG levels
were detectable by day 14, with all four mice having titers
ranging from 1:1,600 to 1:6,400 by day 16 (Table 1). In con-
trast, mice infected with 105 MSK10 organisms showed a re-
duced response relative to their wild-type B. burgdorferi parent
(MSK5), exhibiting a detectable IgG response at day 10 (with
titers varying from undetectable levels up to 1:400) (Table 1)
which peaked by day 21 (titers ranged from 1:400 to 1:3,200)
(Table 1). Serum from ML23 (lp25)-infected animals was
tested at days 1, 2, and 4 and every other day to day 14 for the
inoculums of 103 and 105 organisms, respectively (data not
shown). No IgM or IgG antibody titer was detected for either
inoculum (data not shown). Taken together, these results in-
FIG. 1. Kinetics of bacterial dissemination in C3H/HeN mice infected with either wild-type B. burgdorferi cells (MSK5) at an inoculum of 103
(A) or 105 (B) organisms, lp28-1 cells (MSK10) at an inoculum of 103 (C) or 105 (D) organisms, or lp25 cells (ML23) at an inoculum of 103
(E) or 105 (F) organisms. Groups of four mice were sacrificed per time point indicated. The y axis indicates the total number of tissues tested that
were infected, and each patterned box represents a specific tissue. The value shown for an individual tissue indicates the number of positive animals
out of the four animals infected. LN, lymph node; ND, not determined.
TABLE 1. Range of IgM and IgG antibody titers elicited by infection with B. burgdorferi strain B31 isolates MSK5 (wild type) and
MSK10 (lp28-1)a
Days
postinfection
MSK5 (wild type) MSK10 (lp28-1)
IgM antibody titer with inoculum
of:
IgG antibody titer with inoculum
of:
IgM antibody titer with
inoculum of:
IgG antibody titer with
inoculum of:
103 cells 105 cells 103 cells 105 cells 103 cells 105 cells 103 cells 105 cells
1 —b — — — — — — —
2 — — — — — — — —
4 0–800c — — — — — — —
6 0–800c — — — — — — —
8 — 800–3,200 — — — 800–3,200 — —
10 1,600–3,200 1,600–3,200 — — 0–3,200c 1,600–6,400 — 0–400c
12 1,600–6,400 1,600–3,200 0–1,600c — 0–200c 800–3,200 0–200c 0–800c
14 3,200–12,800 1,600–3,200 3,200d 1,600d 0–1,600c 200–400 — 0–800c
16 6,400d 800–1,600 6,400–2,800 1,600–6,400 0–1,600c 0–1,600c 0–3,200c 200–1,600
18 0–3,200c 400–1,600 0–12,800c 0–6,400c 0–400c 0–1,600c 0–800c 800–1,600
21 0–800c 200–1,600 0–2,800c 0–12,800c — 0–400c 0–200c 400–3,200
a Four mice were sacrificed per time point per inoculum size (either 103 or 105 organisms). Antibody titers were calculated for each individual mouse and are listed
as the range observed for four animals per time point.
b —, no detectable antibody titer for any of the four mice at the time point and inoculum given.
c At least one of the 4 mice tested had no detectable antibody titer at this time point.
d All four mice had the same titer at the time point and inoculum.
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dicate a dose dependence of the humoral response for IgG in
both MSK5 and MSK10, as titers took longer to develop at the
lower inoculum dose; no such correlation was found for the
IgM response (Table 1). As previously reported (3–5, 7), the
wild-type infectious isolate elicits a strong humoral response
yet still disseminates and persists inside the host (Fig. 1 and
Table 1), indicating that wild-type B. burgdorferi is able to avoid
antibody-based clearance mechanisms due to immune-pro-
tected niches it occupies in the host and/or to antigenic evasive
mechanisms, including both antigen variation and potential
phase-variable mechanisms (20, 21, 32, 33). In contrast,
MSK10 cells are cleared coincidently with the appearance of B.
burgdorferi-specific IgM, suggesting that the absence of lp28-1
puts B. burgdorferi at significant risk of humoral-response-
based clearance mechanisms.
Kinetics of infection in C3H/HeN scid mice. Because the
bacterial clearance from tissues in the MSK10 (lp28-1)-in-
fected animals correlated with the development of an adaptive
immune response (i.e., specific antibodies), we tested the abil-
ity of the lp28-1 mutant to colonize mice lacking active immu-
nity. To address this, the infection kinetics experiment de-
scribed above for immunocompetent mice was repeated with
C3H scid mice. If the lp28-1 cells are cleared from the ani-
mals in an antibody-dependent manner, then the MSK10 iso-
late should have a pattern of infection in scid mice similar to
that of wild-type parent strain MSK5 in immunocompetent
mice. The same infection protocol used for immune-compe-
tent mice was used to infect the scid mice except that the time
points varied (see Materials and Methods for details). As pos-
itive controls, we infected scid mice with 103 and 105 MSK5
organisms and found that they demonstrated similar infectivity
kinetics relative to C3H/HeN mice (Fig. 2A and B, respective-
ly). Results shown in Fig. 2C and D indicated that MSK10 was
able to disseminate and persist in all the tissues tested just as
wild-type organisms do in immunocompetent mice, regardless
of the infectious dose (compare Fig. 1A and B with Fig. 2C and
D). As with the immunocompetent mice, the lp25 cells did
not survive in scid mice (data not shown). These results support
the hypothesis that the lp28-1 mutant organisms are cleared by
the adaptive immune response and also rule out the possibility
that innate immune mechanisms (i.e., dendritic cells, natural
killer cells, complement, etc.) are responsible for the clearance of
MSK10 observed in immunocompetent animals, since these mo-
dalities are operative in the scid mice as well.
DISCUSSION
We have previously shown that B. burgdorferi B31 lacking
plasmid lp28-1 can be recovered from the joints 2 weeks after
infection; however, when plasmid lp25 is missing, organisms
cannot be recovered from mice infected with inocula as high as
105 bacteria (17). We suspected that immune mechanisms
might explain the differential clearance observed for the lp25
and lp28-1 isolates. To test this hypothesis, we conducted a
kinetic infection experiment over a period of 3 weeks to com-
pare the dissemination in the mouse model of infection of the
mutant strains relative to that of their isogenic parent and
determine the differential humoral response to each strain
tested. The results reported here indicate that B. burgdorferi
strain B31 lacking lp25 does not survive in mice, as organisms
are not detectable in host tissue 24 to 48 h after intradermal
inoculation. In contrast, cells of B. burgdorferi strain B31 lack-
ing lp28-1 disseminate to all tissues tested but are cleared
starting at day 8 or day 10, depending on the inoculum (Fig. 1C
and D) and coincidently with the appearance of a B. burgdor-
feri-specific IgM response (Table 1), until the spirochetes are
eliminated from all tissues by day 18 (Fig. 1C and D).
Since our previous study was limited to a single 2-week time
point, we did not know the timing in which the mutants were
cleared from the host. Interestingly, the lp28-1 mutant dissem-
inated to all tissues tested, whereas the lp25 mutant was recovered
only from the skin, lymph nodes, or spleen (depending on inoc-
ulum size) 24 h following infection but not at the 48-h time point,
indicating that the lp25 mutant is not able to survive within the
FIG. 2. Kinetics of bacterial dissemination in C3H scid mice infected with 103 (A) or 105 (B) wild-type B. burgdorferi cells (MSK5) or 103 (C) or
105 (D) lp28-1 cells (MSK10). Two mice were sacrificed per time point indicated. The y axis indicates the total number of tissues tested that were
infected, and each patterned box represents a specific tissue. The value shown for an individual tissue indicates the number of positive animals out
of the two animals infected. LN, lymph node.
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host (Fig. 1E and F). Based on these results, and in conjunction
with serological analysis, we determined that clearance of the
lp28-1 mutant was superimposable with the peak of a B. burgdor-
feri-specific IgM response (Fig. 1 and Table 1). No detectable
humoral response was detected for the lp25 mutant. Thus, the
absence of either lp25 or lp28-1 puts these mutants at risk of
clearance from the host due to distinct mechanisms.
In the case of the lp25 mutants, their inability to survive
within the infected host suggests that they are either cleared by
innate immune mechanisms or have a metabolic defect ren-
dering them incapable of replication within the murine host
(and presumably other mammals). Our attempts to address the
innate immune mechanisms, specifically, complement sensitiv-
ity, have been inconclusive, since all B. burgdorferi B31 isolates
used in this study demonstrated complete resistance to guinea
pig complement (data not shown) despite controls indicating
that the complement utilized was active (data not shown).
Careful analysis of the open reading frames on lp25 indicated
that the plasmid contains several paralogous genes found on all
B. burgdorferi plasmids that are involved in plasmid partition-
ing to daughter cells and additional loci that either encode
small peptides, contain frameshifts, or are pseudogenes (9, 14).
Only two genes on lp25 are unique to this plasmid. One en-
codes a type IV restriction-modification enzyme that has re-
cently been shown to function as a transformation barrier,
since strains lacking lp25 are transformable with plasmid DNA,
whereas the parental isolate were not (18). The other gene
unique to lp25 encodes a nicotinamidase. The nicotinamidase
is involved in the biochemical pathway that converts nicotin-
amide to nicotinate, both of which serve as precursors in the
synthesis of intracellular NAD. Because B. burgdorferi does not
encode cytochromes and thus does not utilize oxidative phos-
phorylation for energy production, substrate level phosphory-
lation via the glycolytic pathway is important in generating
intracellular ATP (14). Thus, de novo synthesis of NAD via the
nicotinamide-scavenging pathway is important for homeostasis
in B. burgdorferi. Recently Purser et al. demonstrated that the
nicotinamidase gene was sufficient to complement the lp25
noninfectious phenotype, indicating that the NAD biosynthetic
pathway is essential for the survival of B. burgdorferi in a mam-
malian host (26). Furthermore, our kinetic studies indicate that
the requirement of the nicotinamidase gene is absolute, since B.
burgdorferi lacking this enzyme is unable to survive in the mam-
malian host 24 to 48 h following inoculation (Fig. 1E and F).
In contrast to the cells lacking lp25, lp28-1 mutants were
able to disseminate to all tissues tested but were cleared coin-
cidently with the appearance of an IgM response specific for B.
burgdorferi (Fig. 1 and Table 1), indicating that the lack of
lp28-1 abrogated the ability of the mutant to evade the host
humoral immune response and persist like the parent isolate.
The parent strain exhibited the well-characterized robust hu-
moral immune response that is insufficient in clearing B. burg-
dorferi from the host (4, 5), indicating that this immune re-
sponse-evasive activity is directly or indirectly associated with
proteins that are encoded by lp28-1 (Fig. 1 and 2). The most
likely candidate is the lp28-1-encoded antigenic variant VlsE
(32). The vls locus contains 15 silent cassettes and an expres-
sion site near the 3 telomeric end that comprise roughly one-
third of the entire plasmid. Previous studies have shown that
the silent cassettes are sources for multiple nonreciprocal re-
combination events with the expressed locus that give rise to
large numbers of distinct antigenic variants during infection
(21, 32, 33).
The crystal structure of VlsE shows that the variable do-
mains reside on the surface of the molecule where one would
expect opsonogenic antibodies to bind (12). Based on the high
degree of complexity associated with vls recombinational vari-
ants, the antibody response of the host to these variable do-
mains is incapable of keeping pace with the heterogeneity of
the VlsE variants produced per unit organism in a given pop-
ulation. As such, each individual B. burgdorferi cell will express
a unique VlsE variant that, when processed by the host, will
yield an immune response that is incapable of neutralizing the
antigenically distinct VlsE molecules produced subsequently
(21, 32, 33).
Our results demonstrate that mutants lacking lp28-1 alone
are unable to persist in the face of a modest and variable
humoral immune response generated by the host based on the
low antibody titers observed following infection with the
lp28-1 mutant (Table 1). Furthermore, the importance of the
acquired immune response against the lp28-1 mutant as a
clearance mechanism was corroborated by the results obtained
using infected scid mice (Fig. 2). scid mice are deficient in T
and B lymphocyte production and as such cannot generate
either a cellular or humoral response to pathogens. When scid
mice were infected with the lp28-1 mutant, we found that the
infectivity profiles were indistinguishable from the parent
strain with B. burgdorferi cultivated from all tissues tested,
whether lp28-1 was present or not (Fig. 2), indicating that the
clearance of the lp28-1 isolate in immunocompetent mice re-
quired an adaptive immune response. The fact that the clear-
ance of the lp28-1 mutant correlated with the peak of IgM
response in the immunocompetent mouse suggests that the
basis of the differential clearance of the lp28-1 mutant seen in
the C3H/HeN mice is due to humoral immune mechanisms
(Fig. 1 and 2 and Table 1).
Our contention that the clearance mechanism observed for
the lp28-1 mutant is due to humoral immune mechanisms is
supported by studies demonstrating that T-cell depletion does
not alter the course of experimental Lyme borreliosis (23).
Furthermore, passive immunizations from both immunocom-
petent and T-cell-deficient mice provide protection against
experimental infection, thus corroborating the importance of
antibodies in the clearance of B. burgdorferi (4, 6, 11). Re-
cently, Philipp et al. suggested that VlsE might be a T-cell-
independent antigen that could directly stimulate B cells to
produce antibodies (25). Such a response would be absent in
the lp28-1 mutants lacking the vls system. If one assumes that
the basis for the lp28-1 phenotype is directly linked to VlsE,
then wild-type cells containing VlsE are capable of modulating
the humoral immune response via antigenic variants that ac-
cumulate over time. Alternatively, because VlsE is an immu-
nodominant antigen (19), the potent humoral response it en-
genders may override the production of antibodies against
other potentially protective antigens. Thus, in the case of the
lp28-1 mutant, the absence of VlsE allows for efficient processing
of antigens via conventional T-cell-dependent immune responses
that results in the development of antibodies that neutralize and
kill vls-lacking B. burgdorferi organisms within the infected mam-
mal. As such, it may be possible to use the lp28-1 mutant to
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identify non-Vls antigens that may prevent colonization of infec-
tious B. burgdorferi and thus confer protection. This approach
would require high-titer borrelicidal antibodies that would neu-
tralize infectious B. burgdorferi prior to the induction of the Vls-
specific T-cell-independent response.
While it is possible that genes other than vls and its cassettes
on lp28-1 are responsible for the phenotype of the lp28-1
mutant, this seems unlikely, inasmuch as most of these loci (20
out of 32) are either paralogues found on other borrelial plas-
mids, frameshifted genes, or pseudogenes (9, 14). In fact, only
12 loci encode novel products. Eleven are polypeptides of 99
amino acids or less that have no known functional homologues;
the remaining unique locus is the vls system. Furthermore, the
significant dedication of such a large component of this plas-
mid (8 kb) to vls provides further support that this system is
a key component of host immune evasion and the overall
pathogenic strategy of B. burgdorferi. Nevertheless, until ge-
netic knockouts are generated that specifically inactivate the
vlsE expression site, or other equivalent genetic studies that
exclude the effect of the other non-vls genes on lp28-1 are
performed, the net effect of antigenic variation as the lone
lp28-1-specific pathogenic mechanism used by B. burgdorferi
will remain unresolved. With the recent advent of improved
genetic systems for infectious B. burgdorferi mutagenesis (13,
28), the ability to conduct such studies is certainly forthcoming.
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